Related references
Note: Only part of the references are listed.Human organic cation transporter 1 (hOCT1) as a mediator of bendamustine uptake and cytotoxicity in chronic lymphocytic leukemia (CLL) cells
C. Arimany-Nardi et al.
PHARMACOGENOMICS JOURNAL (2015)
Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions
C. Arimany-Nardi et al.
PHARMACOGENOMICS JOURNAL (2015)
Expression of SLC22A1 Variants May Affect the Response of Hepatocellular Carcinoma and Cholangiocarcinoma to Sorafenib
Elisa Herraez et al.
HEPATOLOGY (2013)
Organic cation transporters OCT1 and OCT2 determine the accumulation of lamivudine in CD4 cells of HIV-infected patients
N. Jung et al.
INFECTION (2013)
Organic Cation Transporter 1 (OCT1/mOct1) Is Localized in the Apical Membrane of Caco-2 Cell Monolayers and Enterocytes
Tianxiang (Kevin) Han et al.
MOLECULAR PHARMACOLOGY (2013)
Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake
Min-Koo Choi et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2012)
The cysteines of the extracellular loop are crucial for trafficking of human organic cation transporter 2 to the plasma membrane and are involved in oligomerization
Sabine Brast et al.
FASEB JOURNAL (2012)
No Correlation between the Expression of FXR and Genes Involved in Multidrug Resistance Phenotype of Primary Liver Tumors
P. Martinez-Becerra et al.
MOLECULAR PHARMACEUTICS (2012)
A quantitative basis for antiretroviral therapy for HIV-1 infection
Benjamin L. Jilek et al.
NATURE MEDICINE (2012)
The Large Extracellular Loop of Organic Cation Transporter 1 Influences Substrate Affinity and Is Pivotal for Oligomerization
Thorsten Keller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions
G. Ahlin et al.
PHARMACOGENOMICS JOURNAL (2011)
The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
M. V. Tzvetkov et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Expression of Organic Cation Transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) Is Affected by Genetic Factors and Cholestasis in Human Liver
Anne T. Nies et al.
HEPATOLOGY (2009)
Transport of Lamivudine [(-)-β-L-2′,3′-Dideoxy-3′-thiacytidine] and High-Affinity Interaction of Nucleoside Reverse Transcriptase Inhibitors with Human Organic Cation Transporters 1, 2, and 3
Gerard Minuesa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection
Norma Jung et al.
DRUG METABOLISM AND DISPOSITION (2008)
Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics
Y. Shu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Expression and functionality of anti-human immunodeficiency virus and anticancer drug uptake transporters in immune cells
Gerard Minuesa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications
Hermann Koepsell et al.
PHARMACEUTICAL RESEARCH (2007)
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Yan Shu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1
Y Shu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences
R Kerb et al.
PHARMACOGENETICS (2002)
Share Paper
